Idexx Laboratories
IDXX · NASDAQ · USD · Healthcare
1What is happening
Idexx Laboratories has fallen 5% since its 6-week high on 04/11/2026. How it continues – phase and signs – you see with a free account.
Free account · 3 stocks and coins a dayfrom the 6-week high-5.3%
Other view · 12 analystsHorizon: 12 months9 Buy · 4 Hold · 1 Sell2Our assessment
No dip38How it continues – phase and signs – you see with a free account.
3Your next step
Marking places no order – it only helps you keep track.
More details · reasons, figures, alerts
How deep is the dip?
- from the 6-week high-5.3%
Highest daily price: $713.74 on 04/11/2026 · reference of the assessment · also the highest of the last 3 months
- from the 52-week high-12.2%
Highest price in 52 weeks: $769.98 (Yahoo)
What analysts expect
Most of the 12 analysts say buy. They look about 12 months ahead – DipCatcher only 14 trading days.
- Buy
- 964 %
- Hold
- 429 %
- Sell
- 17 %
Average price target$717.17
$470.00 to $810.00 · today $676.04
$470.00Ø $717.17$810.00
What is a price target?
The price an analyst expects in about 12 months. Estimates are often far apart and change frequently.
Third-party opinion, not an assessment by DipCatcher. Source: public analyst estimates, as of 08/11/2026. Not financial advice.
Dates
- 1FebQuarterly resultsIdexx Laboratories reports results. Prices often move more around this date.
The company in figures
- Market value
- 53.3 bn $
- All shares together at the current price.
- P/E
- 45.6
- Price divided by earnings per share, last 12 months.
- 52-week range
- $500.61 – $769.98
- Lowest and highest price of the last year.
Catalysts
42 h ago- News, last 10 days
- no recent news
- Next earnings
- 01/02/2027 · in 87 days
- Last report
- 02/11/2026 +8.0% vs estimate
Key figures
- Market value
- 53.3 bn $Large cap
- P/E
- 45.6
- Volume today
- 1.0 × Øabout usual
- Beta
- 1.54swings more than the market
- 52-week range
- $500.61 – $769.98price at 65 % of the range
About Idexx Laboratories
IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. It operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. The company offers point-of-care diagnostic solutions, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology/morphology, and coagulation analyzers; and SNAP rapid assays test kits. It also provides commercial reference laboratory diagnostic and consulting services to veterinarians; veterinary consultation, telemedicine, and advisory services, including radiology, dental radiography, cardiology, internal medicine, and ultrasound consulting; Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, Quanti-Tray products, and Tecta system instruments; UV Viewer Plus, a UV light cabinet which aids in the visual interpretation of fluorescent-based water tests; and veterinary software and services for independent veterinary clinics and corporate groups. In addition, the company offers diagnostic tests, services, and related instrumentation to manage the health status of livestock and poultry; human medical diagnostic products and services; and VetConnect PLUS, a cloud-based technology that enables veterinarians to access and analyze patients, as well as operates VetLab Station. It markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.
- Headquarters:
- Westbrook, United States
- 52-week range:
- $500.61 – $769.98
- Website:
- idexx.com
Trade levels
Why the engine says so
History for this stock or coin
Watch and alert
See which stocks they are
The engine is watching these dips right now. A free account shows the names and opens 3 full analyses a day.
- 3 full analyses a dayWith entry, target, stop and the reasons behind them.
- WatchlistFollow the stocks you care about.
Free, no payment details.
Signals are generated automatically from price, volume and technical indicators. They are not investment advice.← Back to search
Not investment advice. Investing carries risk up to total loss.